Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up.
about
The risks of overlooking the diagnosis of secreting pituitary adenomasProlactinoma ErbB receptor expression and targeted therapy for aggressive tumors.Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis.Genomic characterization of human and rat prolactinomas.Clinical course of hyperprolactinemia in children and adolescents: a review of 21 cases.Invasive adenoma and pituitary carcinoma: a SEER database analysisCorrelations of pituitary tumor transforming gene expression with human pituitary adenomas: a meta-analysis.Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.CRMP1 Inhibits Proliferation of Medulloblastoma and Is Regulated by HMGA1Clinical review: Pituitary carcinoma: difficult diagnosis and treatmentDeregulation of miR-183 and KIAA0101 in Aggressive and Malignant Pituitary TumorsGene expression profiling analysis of MENX-associated rat pituitary adenomas contributes to understand molecular mechanisms of human pituitary adenomas.Pituitary tumor-transforming gene and its binding factor in endocrine cancer.Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment.Giant prolactinomas: the therapeutic approach.Epidemiology and etiopathogenesis of pituitary adenomas.Management of aggressive pituitary adenomas and pituitary carcinomas.Aggressive pituitary adenomas--diagnosis and emerging treatments.Surgical treatment of microprolactinomas: pros.In search of a prognostic classification of endocrine pituitary tumors.10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas.New targeted therapies in pituitary carcinoma resistant to temozolomide.Reasons and results of endoscopic surgery for prolactinomas: 142 surgical cases.Isolation and characterization of a novel noncoding RNA from nickel-induced lung cancer.Medically treated prolactin-secreting pituitary adenomas: when should we operate?Integrated genomic profiling identifies loss of chromosome 11p impacting transcriptomic activity in aggressive pituitary PRL tumors.Expression of pituitary tumor transforming gene (PTTG) in human pituitary macroadenomas.Aggressive and malignant prolactin pituitary tumors: pathological diagnosis and patient management.A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up.Endothelial expression of endocan is strongly associated with tumor progression in pituitary adenoma.Bioinformatic analysis of gene expression profiles of pituitary gonadotroph adenomas.Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference.Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma.The Chance of Permanent Cure for Micro- and Macroprolactinomas, Medication or Surgery? A Systematic Review and Meta-Analysis
P2860
Q28076665-B4E01D85-8362-4658-B801-C3D2BC69C51EQ33680681-B02BE966-EEBA-4F36-BA6C-681A6D5E1E51Q34019857-40EC2358-9355-486B-8B4A-FD40F4F9AD15Q34277575-6B74EE79-521A-41DF-93AB-5E542E9C6497Q35058041-28A1C294-BCCA-4482-A4EF-36F4C9AEB9ECQ35067759-217CB9D2-9E76-441C-9E3E-F1C770A31861Q35110682-C03E1F2E-52A8-4E9C-AC62-26C1AD023F82Q35530288-EF56467E-814D-4FDB-BBFC-2BF78590CF8EQ35640979-39175BED-E33D-45DC-BD7B-4A6B3229EE77Q35750569-41909409-3CD8-4685-AACC-6DE38536D367Q35932525-F29AC085-FC5D-4E55-BB7E-E528214D235BQ36503152-E7578E67-A531-4D36-B269-B18AF646477EQ37815569-ED360AAE-515D-45E8-9D57-131FBF7031BDQ37992191-23F971A5-2E51-464F-A81D-B61A0E0C18D2Q38105620-B7961D1A-D486-430D-80F2-C70EB2979DA5Q38183762-39E2E0A0-A5D8-4899-B051-D061BF4EF806Q38192486-CD89BEDD-A56D-488D-A504-BE10FAEBBA31Q38211375-534BE8A0-28D9-45CC-A1F0-CAC7F4238F55Q38211820-B11E7EB9-47F8-4938-BF64-BBE89A8F487AQ38212659-CAFA24B2-B8EE-4CAA-8233-BF46F24042D2Q39336294-5307E56B-3A35-43A2-82E2-66432A579F86Q39715502-79BC1574-B082-4A85-A328-434169C5C586Q39925726-02534231-D22F-4457-BED2-694779D9F531Q42651794-7A7223C9-E15A-4BC4-864D-C1DE6C83F675Q44195590-4D967A0C-D03A-4D07-B251-6CA6A3F40730Q44588158-233F4FCE-4314-4A43-BFC3-4B2BE07C9BDBQ44926164-DD736173-1529-49DD-9CFF-84B6F7424BB6Q46316098-12E612A8-8F0E-4C33-9E49-22A6FCBC7610Q46411571-78826B28-92AA-4304-8C95-BB83313490FCQ48649719-B9727735-D5B2-4779-ADF4-980232054A5DQ50053755-EECEF5F0-522B-4B87-8F27-A5182718EF3FQ50995901-E3F3D42E-AB79-4CE8-B30E-A3A281428574Q53556241-3F97FA3D-7CC4-46B2-9570-0BE083958380Q55461027-7FB8FCA5-4985-4660-8E9F-2D1546B24ED9Q58556107-BBA8DC9D-7275-45CD-8010-B6727445F223
P2860
Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prognostic factors in prolacti ...... long postoperative follow-up.
@ast
Prognostic factors in prolacti ...... long postoperative follow-up.
@en
Prognostic factors in prolacti ...... long postoperative follow-up.
@nl
type
label
Prognostic factors in prolacti ...... long postoperative follow-up.
@ast
Prognostic factors in prolacti ...... long postoperative follow-up.
@en
Prognostic factors in prolacti ...... long postoperative follow-up.
@nl
prefLabel
Prognostic factors in prolacti ...... long postoperative follow-up.
@ast
Prognostic factors in prolacti ...... long postoperative follow-up.
@en
Prognostic factors in prolacti ...... long postoperative follow-up.
@nl
P2093
P50
P356
P1476
Prognostic factors in prolacti ...... long postoperative follow-up.
@en
P2093
Carole Auger
Emmanuel Jouanneau
Guillaume Chapas
HYPOPRONOS
Jacqueline Trouillas
Joël Lachuer
Michel Jan
P304
P356
10.1210/JC.2009-1191
P407
P50
P577
2010-02-17T00:00:00Z